Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Non-Hodgkin's Lymphoma treatment details. Immunotherapy. Mayo Clinic and Mayo Foundation, Rochester, MN, United States



Survival: 27.6 months
   
Toxicity Grade: 4
   
Treatments: Immunotherapy
   
Drugs:
Country: United States
   
City/State/Province: Rochester, MN
   
Hospital: Mayo Clinic and Mayo Foundation
   
Journal: Link
   
Date: 7/2007

Description:
Patients:
This study involved 41 patients with non-Hodgkin’s lymphoma. The median patient age was 65 years and 44% were male.

Treatment:
Patients were treated with the immunotherapy agent interleukin-4 (IL-4), which stimulates the immune system to attack cancer cells.

Toxicities:
The most severe adverse event was one case of grade 4 vomiting. Grade 3 headache, fatigue, congestive heart failure (not leading to death), and swelling were also reported.

Results:
The median overall survival was 27.6 months.

Support:
The study drug was provided by the pharmaceutical company Schering-Plough.

Correspondence: Dr. Thomas Witzig; email: witzig@mayo.edu

E-mail to a Friend Email Physician More Information